Nuclear Medicine: Page 16
Ablaze secures peptide drug license from RayzeBio
March 30, 2023
On Target Laboratories touts Cytalux study results
March 26, 2023
FIND Act reintroduced in Congress
March 6, 2023
GE HealthCare completes recruitment for contrast development
February 28, 2023
GE HealthCare close to completing safety recall
February 23, 2023
GE HealthCare recalls certain nuclear medicine systems
February 15, 2023









